Akapelwa Mwangala L, Kapalamula Thoko F, Moonga Lavel C, Bwalya Precious, Solo Eddie S, Chizimu Joseph Y, Thapa Jeewan, Hayashida Kyoko, Hang'ombe Bernard M, Munyeme Musso, Tamaru Aki, Wada Takayuki, Yoshida Shiomi, Kodera Takuya, Kawase Mistuo, Gordon Stephen V, Yamada Keiko, Nakajima Chie, Suzuki Yasuhiko
Division of Bioresources, Hokkaido University International Institute for Zoonosis Control, Sapporo, Japan.
Department of Pathobiology, Faculty of Veterinary Medicine, Lilongwe University of Agriculture and Natural Resources, Lilongwe, Central Region, Malawi.
Microbiol Spectr. 2025 Jun 3;13(6):e0242124. doi: 10.1128/spectrum.02421-24. Epub 2025 Apr 30.
Although human tuberculosis (TB) caused by is clinically, pathologically, and radiologically indistinguishable from -caused TB, is innately resistant to pyrazinamide, a key first-line drug effective against . The rapid differentiation of these two biovars is therefore of high clinical and epidemiologic importance. Most current molecular tools in resource-limited settings identify mycobacteria only to the species (MTB) level. In this study, we report a multiplex loop-mediated isothermal amplification (LAMP) method coupled with dipstick chromatography for the rapid and easy differential detection of and . The assay was optimized and validated using 143 isolates comprising six MTB reference strains, 50 . isolates, 58 . isolates, 24 non-tuberculous mycobacterial (NTM) strains, and five other respiratory pathogens. The multiplex LAMP correctly detected MTB and distinguished between and simultaneously with sensitivities of 500 fg and 1 pg DNA, respectively, within 60 min, and the results were visualized by dipstick chromatography within 10 min. The assay was specific in that no major respiratory pathogens tested, including NTM strains, were positive. The multiplex dipstick LAMP assay is therefore a useful and accurate low-cost method for the differential identification of and , especially in endemic areas where bovine and human TB coexist. The distinction between and can also aid in monitoring the spread of to humans and allow for correct treatment, which will ultimately contribute to TB control in both humans and animals.
Human tuberculosis caused by and shows similar clinical symptoms; however, the treatment differs because is inherently resistant to pyrazinamide, a key first-line drug effective against . Most available molecular tools cannot distinguish the two biovars. This study addresses this gap by introducing a multiplex loop-mediated isothermal amplification (LAMP) method coupled with dipstick chromatography that can simultaneously and differentially detect and within 60 min. The LAMP method does not require sophisticated high-cost equipment and can be easily implemented in resource-limited settings. Our LAMP facilitates rapid and accurate tuberculosis diagnosis, enabling appropriate therapeutic agents to be selected in areas where bovine and human tuberculosis coexist. It can also screen for infection in humans and livestock, providing prevalence data in areas where such information is lacking.
虽然由[具体细菌名称1]引起的人类结核病在临床、病理和放射学上与由[具体细菌名称2]引起的结核病无法区分,但[具体细菌名称1]对吡嗪酰胺天然耐药,而吡嗪酰胺是一种对[具体细菌名称2]有效的关键一线药物。因此,快速区分这两种生物变种具有很高的临床和流行病学重要性。在资源有限的环境中,目前大多数分子工具只能将分枝杆菌鉴定到[结核分枝杆菌复合群]物种(MTB)水平。在本研究中,我们报告了一种多重环介导等温扩增(LAMP)方法,并结合试纸条色谱法,用于快速简便地鉴别[具体细菌名称1]和[具体细菌名称2]。该检测方法使用143株菌株进行了优化和验证,这些菌株包括6株MTB参考菌株、50株[具体细菌名称1]菌株、58株[具体细菌名称2]菌株、24株非结核分枝杆菌(NTM)菌株以及5种其他呼吸道病原体。多重LAMP能够正确检测MTB,并同时区分[具体细菌名称1]和[具体细菌名称2],分别在60分钟内对500 fg和1 pg DNA具有敏感性,结果可在10分钟内通过试纸条色谱法可视化。该检测方法具有特异性,即所检测的主要呼吸道病原体(包括NTM菌株)均为阴性。因此,多重试纸条LAMP检测方法是一种有用且准确的低成本方法,用于鉴别[具体细菌名称1]和[具体细菌名称2],特别是在牛结核病和人类结核病共存的流行地区。区分[具体细菌名称1]和[具体细菌名称2]也有助于监测[具体细菌名称1]向人类的传播,并实现正确治疗,最终有助于人类和动物的结核病防控。
由[具体细菌名称1]和[具体细菌名称2]引起的人类结核病表现出相似的临床症状;然而,治疗方法不同,因为[具体细菌名称1]对吡嗪酰胺天然耐药,而吡嗪酰胺是一种对[具体细菌名称2]有效的关键一线药物。大多数现有的分子工具无法区分这两种生物变种。本研究通过引入一种多重环介导等温扩增(LAMP)方法并结合试纸条色谱法来解决这一差距,该方法能够在60分钟内同时且区分性地检测[具体细菌名称1]和[具体细菌名称2]。LAMP方法不需要复杂的高成本设备,并且可以在资源有限的环境中轻松实施。我们的LAMP有助于快速准确地诊断结核病,能够在牛结核病和人类结核病共存的地区选择合适的治疗药物。它还可以筛查人类和牲畜中的[具体细菌名称1]感染,在缺乏此类信息的地区提供流行率数据。